{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T06:11:08Z","timestamp":1782540668140,"version":"3.54.5"},"reference-count":47,"publisher":"Elsevier BV","issue":"34","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,16]],"date-time":"2016-06-16T00:00:00Z","timestamp":1466035200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000277","name":"Department for Environment, Food and Rural Affairs","doi-asserted-by":"publisher","award":["SE3226"],"award-info":[{"award-number":["SE3226"]}],"id":[{"id":"10.13039\/501100000277","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.vaccine.2016.06.032","type":"journal-article","created":{"date-parts":[[2016,6,22]],"date-time":"2016-06-22T19:35:07Z","timestamp":1466624107000},"page":"4003-4011","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Parenteral adenoviral boost enhances BCG induced protection, but not long term survival in a murine model of bovine TB"],"prefix":"10.1016","volume":"34","author":[{"given":"Daryan A.","family":"Kaveh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Carmen","family":"Garcia-Pelayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul R.","family":"Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esen E.","family":"Wooff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique S.","family":"Bachy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip J.","family":"Hogarth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.06.032_b0005","doi-asserted-by":"crossref","first-page":"325","DOI":"10.20506\/rst.20.1.1266","article-title":"Epidemiology of selected mycobacteria that infect humans and other animals","volume":"20","author":"Ashford","year":"2001","journal-title":"Rev Sci Tech"},{"key":"10.1016\/j.vaccine.2016.06.032_b0010","series-title":"Tuberculosis: pathogenesis, protection and control","article-title":"The BCG experience: implications for future vaccines against tuberculosis","author":"Bloom","year":"1994"},{"key":"10.1016\/j.vaccine.2016.06.032_b0015","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1211\/jpp.58.6.0005","article-title":"Development of vaccines against bovine tuberculosis","volume":"58","author":"Hogarth","year":"2006","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.vaccine.2016.06.032_b0020","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.micinf.2005.03.009","article-title":"Prime-boost immunisation strategies for tuberculosis","volume":"7","author":"McShane","year":"2005","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2016.06.032_b0025","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.tube.2011.12.003","article-title":"BCG: myths, realities, and the need for alternative vaccine strategies","volume":"92","author":"McShane","year":"2012","journal-title":"Tuberculosis"},{"key":"10.1016\/j.vaccine.2016.06.032_b0030","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1146\/annurev.immunol.021908.132703","article-title":"Cell-mediated immune responses in tuberculosis","volume":"27","author":"Cooper","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.vaccine.2016.06.032_b0035","doi-asserted-by":"crossref","first-page":"e1002052","DOI":"10.1371\/journal.ppat.1002052","article-title":"A gamma interferon independent mechanism of CD4 T cell mediated control of M. tuberculosis infection in vivo","volume":"7","author":"Gallegos","year":"2011","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2016.06.032_b0040","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tube.2006.01.017","article-title":"Use of recombinant virus-vectored tuberculosis vaccines for respiratory mucosal immunization","volume":"86","author":"Xing","year":"2006","journal-title":"Tuberculosis"},{"key":"10.1016\/j.vaccine.2016.06.032_b0045","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0140-6736(13)60177-4","article-title":"Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial","volume":"381","author":"Tameris","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2016.06.032_b0050","doi-asserted-by":"crossref","first-page":"205ra134","DOI":"10.1126\/scitranslmed.3006843","article-title":"A human type 5 adenovirus-based tuberculosis vaccine induces robust T cell responses in humans despite preexisting anti-adenovirus immunity","volume":"5","author":"Smaill","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2016.06.032_b0055","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1016\/j.vaccine.2004.11.030","article-title":"Protective immunity against Mycobacterium bovis induced by vaccination with Rv3019c\u2013a member of the esat-6 gene family","volume":"23","author":"Hogarth","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.06.032_b0060","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.1128\/IAI.70.10.5446-5453.2002","article-title":"Epitope mapping of the immunodominant antigen TB10.4 and the two homologous proteins TB10.3 and TB12.9, which constitute a subfamily of the esat-6 gene family","volume":"70","author":"Skjot","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.06.032_b0065","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.1128\/IAI.02086-05","article-title":"High frequency of CD4+ T cells specific for the TB10.4 protein correlates with protection against Mycobacterium tuberculosis infection","volume":"74","author":"Hervas-Stubbs","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.06.032_b0070","doi-asserted-by":"crossref","first-page":"e21566","DOI":"10.1371\/journal.pone.0021566","article-title":"Systemic BCG immunization induces persistent lung mucosal multifunctional CD4 TEM cells which expand following virulent mycobacterial challenge","volume":"6","author":"Kaveh","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2016.06.032_b0075","doi-asserted-by":"crossref","first-page":"e38926","DOI":"10.1371\/journal.pone.0038926","article-title":"The duration of antigen-stimulation significantly alters the diversity of multifunctional CD4 T cells measured by intracellular cytokine staining","volume":"7","author":"Kaveh","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2016.06.032_b0080","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/mt.2009.60","article-title":"Immunization with a bivalent adenovirus-vectored tuberculosis vaccine provides markedly improved protection over its monovalent counterpart against pulmonary tuberculosis","volume":"17","author":"Mu","year":"2009","journal-title":"Mol Therapy"},{"key":"10.1016\/j.vaccine.2016.06.032_b0085","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1128\/IAI.00004-07","article-title":"Protective immune responses to a recombinant adenovirus type 35 tuberculosis vaccine in two mouse strains: CD4 and CD8 T-cell epitope mapping and role of gamma interferon","volume":"75","author":"Radosevic","year":"2007","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.06.032_b0090","doi-asserted-by":"crossref","first-page":"4634","DOI":"10.1128\/IAI.00517-06","article-title":"Intranasal boosting with an adenovirus-vectored vaccine markedly enhances protection by parenteral Mycobacterium bovis BCG immunization against pulmonary tuberculosis","volume":"74","author":"Santosuosso","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.06.032_b0095","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/jgm.1487","article-title":"Respiratory mucosal immunization with adenovirus gene transfer vector induces helper CD4 T cell-independent protective immunity","volume":"12","author":"Mu","year":"2010","journal-title":"J Gene Med"},{"key":"10.1016\/j.vaccine.2016.06.032_b0100","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.vaccine.2013.11.045","article-title":"Comparison of the immunogenicity and protection against bovine tuberculosis following immunization by BCG-priming and boosting with adenovirus or protein based vaccines","volume":"32","author":"Dean","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.06.032_b0105","author":"Anonymous"},{"key":"10.1016\/j.vaccine.2016.06.032_b0110","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1017\/S0022172400052943","article-title":"A selective oleic acid albumin agar medium for the cultivation of Mycobacterium bovis","volume":"79","author":"Gallagher","year":"1977","journal-title":"J Hyg"},{"key":"10.1016\/j.vaccine.2016.06.032_b0115","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/sj.gt.3301197","article-title":"A simple method for the rapid generation of recombinant adenovirus vectors","volume":"7","author":"Anderson","year":"2000","journal-title":"Gene Ther"},{"key":"10.1016\/j.vaccine.2016.06.032_b0120","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.tube.2008.05.005","article-title":"Development of a Mycobacterium bovis intranasal challenge model in mice","volume":"88","author":"Logan","year":"2008","journal-title":"Tuberculosis"},{"key":"10.1016\/j.vaccine.2016.06.032_b0125","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1016\/j.vaccine.2012.02.036","article-title":"Preclinical evidence for implementing a prime-boost vaccine strategy for tuberculosis","volume":"30","author":"Brennan","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.06.032_b0130","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/COH.0b013e328363d3b7","article-title":"Nonreplicating vectors in HIV vaccines","volume":"8","author":"Johnson","year":"2013","journal-title":"Curr Opin HIV AIDS"},{"key":"10.1016\/j.vaccine.2016.06.032_b0135","doi-asserted-by":"crossref","first-page":"e106240","DOI":"10.1371\/journal.pone.0106240","article-title":"Homologous boosting with adenoviral serotype 5 HIV vaccine (rAd5) vector can boost antibody responses despite preexisting vector-specific immunity in a randomized phase I clinical trial","volume":"9","author":"Sarwar","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2016.06.032_b0140","doi-asserted-by":"crossref","first-page":"8024","DOI":"10.1128\/JVI.79.13.8024-8031.2005","article-title":"Enhanced breadth of CD4 T-cell immunity by DNA prime and adenovirus boost immunization to human immunodeficiency virus Env and Gag immunogens","volume":"79","author":"Wu","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.06.032_b0145","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1365-2567.2004.01903.x","article-title":"Cellular immune responses induced in cattle by heterologous prime-boost vaccination using recombinant viruses and bacille Calmette-Guerin","volume":"112","author":"Vordermeier","year":"2004","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2016.06.032_b0150","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1002\/eji.200939830","article-title":"Difference in TB10.4 T-cell epitope recognition following immunization with recombinant TB10.4, BCG or infection with Mycobacterium tuberculosis","volume":"40","author":"Billeskov","year":"2010","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2016.06.032_b0155","doi-asserted-by":"crossref","first-page":"e5139","DOI":"10.1371\/journal.pone.0005139","article-title":"CD4 and CD8 T cell responses to the M. tuberculosis Ag85B-TB10.4 promoted by adjuvanted subunit, adenovector or heterologous prime boost vaccination","volume":"4","author":"Elvang","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2016.06.032_b0160","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.tube.2014.10.012","article-title":"BALB\/c mice display more enhanced BCG vaccine induced Th1 and Th17 response than C57BL\/6 mice but have equivalent protection","volume":"95","author":"Garcia-Pelayo","year":"2014","journal-title":"Tuberculosis"},{"key":"10.1016\/j.vaccine.2016.06.032_b0165","first-page":"259","article-title":"Direct comparison of ELISPOT and ELISA-based assays for detection of individual cytokine-secreting cells","volume":"13","author":"Tanguay","year":"1994","journal-title":"Lymphokine Cytok Res"},{"key":"10.1016\/j.vaccine.2016.06.032_b0170","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1006\/mthe.2001.0330","article-title":"Activation of innate immunity in nonhuman primates following intraportal administration of adenoviral vectors","volume":"3","author":"Schnell","year":"2001","journal-title":"Mol Ther"},{"key":"10.1016\/j.vaccine.2016.06.032_b0175","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.0300-9475.2004.01471.x","article-title":"The influence of remaining live BCG organisms in vaccinated mice on the maintenance of immunity to tuberculosis","volume":"60","author":"Olsen","year":"2004","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.vaccine.2016.06.032_b0180","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1365-3083.2012.02683.x","article-title":"Long-term persistence of BCG Pasteur in lungs of C57BL\/6 mice following intranasal infection","volume":"75","author":"Leversen","year":"2012","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.vaccine.2016.06.032_b0185","doi-asserted-by":"crossref","first-page":"6911","DOI":"10.1016\/j.vaccine.2014.10.041","article-title":"Persistent BCG bacilli perpetuate CD4 T effector memory and optimal protection against tuberculosis","volume":"32","author":"Kaveh","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.06.032_b0190","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1128\/IAI.68.5.2948-2953.2000","article-title":"CpG oligodeoxynucleotides and interleukin-12 improve the efficacy of Mycobacterium bovis BCG vaccination in mice challenged with M. tuberculosis","volume":"68","author":"Freidag","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.06.032_b0195","doi-asserted-by":"crossref","first-page":"5526","DOI":"10.1016\/j.vaccine.2005.07.037","article-title":"Frequency of IFN-gamma producing cells correlates with adjuvant enhancement of bacille Calmette-Guerin induced protection against Mycobacterium bovis","volume":"23","author":"Logan","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.06.032_b0200","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.vaccine.2005.07.115","article-title":"Protective efficacy induced by Mycobacterium bovis bacille Calmette-Guerin can be augmented in an antigen independent manner by use of non-coding plasmid DNA","volume":"24","author":"Hogarth","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.06.032_b0205","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/ni.3048","article-title":"The balance between protective and pathogenic immune responses in the TB-infected lung","volume":"16","author":"Orme","year":"2015","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2016.06.032_b0210","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1046\/j.1365-2567.2003.01589.x","article-title":"A DNA prime-live vaccine boost strategy in mice can augment IFN-gamma responses to mycobacterial antigens but does not increase the protective efficacy of two attenuated strains of Mycobacterium bovis against bovine tuberculosis","volume":"108","author":"Skinner","year":"2003","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2016.06.032_b0215","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/nri842","article-title":"Selection and fine-tuning of the autoimmune T-cell repertoire","volume":"2","author":"Anderton","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2016.06.032_b0220","doi-asserted-by":"crossref","first-page":"e0135009","DOI":"10.1371\/journal.pone.0135009","article-title":"AdHu5Ag85A respiratory mucosal boost immunization enhances protection against pulmonary tuberculosis in BCG-primed non-human primates","volume":"10","author":"Jeyanathan","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2016.06.032_b0225","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.tube.2005.04.003","article-title":"Superior virulence of Mycobacterium bovis over Mycobacterium tuberculosis (Mtb) for Mtb-resistant and Mtb-susceptible mice is manifest as an ability to cause extrapulmonary disease","volume":"86","author":"Medina","year":"2006","journal-title":"Tuberculosis"},{"key":"10.1016\/j.vaccine.2016.06.032_b0230","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1073\/pnas.052548299","article-title":"A new evolutionary scenario for the Mycobacterium tuberculosis complex","volume":"99","author":"Brosch","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2016.06.032_b0235","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nri3567","article-title":"Human memory T cells: generation, compartmentalization and homeostasis","volume":"14","author":"Farber","year":"2014","journal-title":"Nat Rev Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1630456X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1630456X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T02:54:42Z","timestamp":1536634482000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1630456X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":47,"journal-issue":{"issue":"34","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0264410X1630456X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.06.032","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Parenteral adenoviral boost enhances BCG induced protection, but not long term survival in a murine model of bovine TB","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.06.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2016 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}